KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Outstanding
Ratios

Teva Pharmaceutical Industries (TEVA) Shares Issued (2016)

Historic Shares Issued for Teva Pharmaceutical Industries (TEVA) over the last 8 years, with Q1 2016 value amounting to $329.0 million.

  • Teva Pharmaceutical Industries' Shares Issued rose 9819.28% to $329.0 million in Q1 2016 from the same period last year, while for Dec 2016 it was $329.0 million, marking a year-over-year decrease of 9000.3%. This contributed to the annual value of $329.0 million for FY2016, which is 9000.3% down from last year.
  • Latest data reveals that Teva Pharmaceutical Industries reported Shares Issued of $329.0 million as of Q1 2016, which was up 9819.28% from $3.0 billion recorded in Q4 2015.
  • In the past 5 years, Teva Pharmaceutical Industries' Shares Issued registered a high of $3.0 billion during Q4 2015, and its lowest value of -$10.0 million during Q4 2012.
  • Moreover, its 5-year median value for Shares Issued was $80.0 million (2014), whereas its average is $249.4 million.
  • Its Shares Issued has fluctuated over the past 5 years, first crashed by 16250.0% in 2012, then soared by 480000.0% in 2014.
  • Teva Pharmaceutical Industries' Shares Issued (Quarter) stood at -$10.0 million in 2012, then soared by 720.0% to $62.0 million in 2013, then skyrocketed by 261.29% to $224.0 million in 2014, then surged by 1217.86% to $3.0 billion in 2015, then crashed by 88.86% to $329.0 million in 2016.
  • Its Shares Issued stands at $329.0 million for Q1 2016, versus $3.0 billion for Q4 2015 and $81.0 million for Q3 2015.